Amring Pharmaceuticals Inc

What does Amring do?

Amring sells uniquely positioned generics that bring value to customers and patients.

We spend every minute of every day figuring out how to bring historically complex prescription medications to market. Our products are generics of value to the market, not high-volume, mass-produced products.

Amring is a proud member of the global pharmaceutical community.

Our strong global network of drug technology and manufacturing gives us the quality and regulatory capability to meet the demands of various niche markets.

Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%

June 23, 2022

Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate Ophthalmic Solution, USP 0.5%, 60 pack of 0.3mL unit dose vials (AT3 rated generic equivalent of Timoptic® in Ocudose®) and has begun commercialization activities.